Abstract
Acute GVHD is an important clinical problem frequently encountered in relation to stem cell transplantation. In its initial treatment glucocorticoids remain the established drug of choice. In the face of the side-effects related to therapy with glucocorticoids other, possibly less toxic, options for the initial treatment of acute GVHD might be of use. We report the successful treatment of progressive cutaneous acute GVHD up to grade II in five pediatric recipients of unrelated marrow grafts.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vettenranta, K., Hovi, L., Parto, K. et al. Very low-dose methotrexate in the treatment of GVHD in children. Bone Marrow Transplant 20, 75–77 (1997). https://doi.org/10.1038/sj.bmt.1700846
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700846